$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000101008619000014 Filed on August 06, 2019

Income Statement

Concept	2019 Q2	2018 Q2	2018 Q1
Revenue	$3.908M	$2.661M	$1.748M
YoY Change	46.86%	-37.61%	-66.4%
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change
Gross Profit	$3.908M	$2.661M	$1.748M
YoY Change	46.86%
Gross Profit Margin	100.0%	100.0%	100.0%
Selling, General & Admin	$3.392M	$2.880M	$3.057M
YoY Change	17.79%	-5.82%	6.52%
% of Gross Profit	86.8%	108.23%	174.89%
Research & Development	$2.038M	$3.312M	$3.008M
YoY Change	-38.46%	-34.65%	-52.7%
% of Gross Profit	52.16%	124.46%	172.08%
Depreciation & Amortization	$127.6K	$4.139K	$29.79K
YoY Change	2982.05%	-89.56%	-17.25%
% of Gross Profit	3.26%	0.16%	1.7%
Operating Expenses	$5.613M	$6.371M	$6.283M
YoY Change	-11.9%	-23.46%	-33.66%
Operating Profit	-$1.705M	-$3.710M	-$4.535M
YoY Change	-54.04%	-8.6%	6.23%
Interest Expense	$3.971M	$3.843M	$3.749M
YoY Change	3.33%	5.22%	3.88%
% of Operating Profit
Other Income/Expense, Net	$737.6K	$144.2K	$2.235K
YoY Change	411.67%	1687.16%	-49.42%
Pretax Income	-$4.282M	-$7.048M	-$11.58M
YoY Change	-39.25%	-195.25%	-236.29%
Income Tax	-$1.100M	$2.849K	-$2.352K
% Of Pretax Income
Net Earnings	-$3.162M	-$7.051M	-$11.58M
YoY Change	-55.15%	-6.0%	34.44%
Net Earnings / Revenue	-80.92%	-264.98%	-662.59%
Basic Earnings Per Share	-$0.04	-$0.09	-$0.15
Diluted Earnings Per Share	-$0.05	-$0.09	-$0.15
COMMON SHARES
Basic Shares Outstanding	80.99M	79.09M shares	79.04M shares
Diluted Shares Outstanding	82.11M	81.16M shares	79.04M shares

Balance Sheet

Concept	2019 Q2	2018 Q2	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$100.3M	$10.60M	$13.90M
YoY Change	846.23%	-65.7%	-53.82%
Cash & Equivalents	$100.3M	$10.58M	$13.93M
Short-Term Investments
Other Short-Term Assets	$14.70M	$106.8M	$12.80M
YoY Change	-86.24%	879.82%	16.36%
Inventory	$2.390M	$2.908M	$2.983M
Prepaid Expenses
Receivables	$4.128M	$2.129M	$1.264M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$121.5M	$122.4M	$30.93M
YoY Change	-0.69%	107.61%	-52.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.860M	$132.6K	$108.9K
YoY Change	2057.18%	-49.59%	-58.66%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$930.0K	$789.9K	$702.2K
YoY Change	17.73%	23.02%	9.36%
Total Long-Term Assets	$81.56M	$5.964M	$102.2M
YoY Change	1267.4%	-93.86%	6.85%
TOTAL ASSETS
Total Short-Term Assets	$121.5M	$122.4M	$30.93M
Total Long-Term Assets	$81.56M	$5.964M	$102.2M
Total Assets	$203.1M	$128.3M	$133.1M
YoY Change	58.24%	-17.75%	-17.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.071M	$1.413M	$432.2K
YoY Change	-24.19%	-59.35%	-80.87%
Accrued Expenses	$10.05M	$3.288M	$3.586M
YoY Change	205.69%	6.15%	21.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.12M	$381.3M	$4.018M
YoY Change	-97.08%	2696.77%	-68.01%
LONG-TERM LIABILITIES
Long-Term Debt	$77.80M	$73.30M	$72.20M
YoY Change	6.14%	6.54%	6.65%
Other Long-Term Liabilities	$10.70M	$15.10M	$391.6M
YoY Change	-29.14%	-95.99%	4.04%
Total Long-Term Liabilities	$88.50M	$88.40M	$463.8M
YoY Change	0.11%	-80.16%	4.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.12M	$381.3M	$4.018M
Total Long-Term Liabilities	$88.50M	$88.40M	$463.8M
Total Liabilities	$99.64M	$469.7M	$467.8M
YoY Change	-78.79%	2.22%	2.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$117.3M	-$556.2M	$200.0K
YoY Change	-78.91%	7.54%	-100.04%
Common Stock	$220.8M	$214.9M	$214.6M
YoY Change	2.73%	0.5%	0.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$103.5M	-$341.3M	-$334.6M
YoY Change
Total Liabilities & Shareholders Equity	$203.1M	$128.3M	$133.1M
YoY Change	58.24%	-17.75%	-17.21%

Cashflow Statement

Concept	2019 Q2	2018 Q2	2018 Q1
OPERATING ACTIVITIES
Net Income	-$3.162M	-$7.051M	-$11.58M
YoY Change	-55.15%	-6.0%	34.44%
Depreciation, Depletion And Amortization	$127.6K	$4.139K	$29.79K
YoY Change	2982.05%	-89.56%	-17.25%
Cash From Operating Activities	-$4.350M	-$5.190M	-$8.562M
YoY Change	-16.18%	208.93%	817.68%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$30.00K
YoY Change	-100.0%	-25.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	$0.00	-$30.00K	$0.00
YoY Change	-100.0%	-25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-10.00K	$0.00
YoY Change	-100.0%	-83.33%	-100.0%
NET CHANGE
Cash From Operating Activities	-4.350M	-5.190M	-$8.562M
Cash From Investing Activities	0.000	-30.00K	$0.00
Cash From Financing Activities	0.000	-10.00K	$0.00
Net Change In Cash	-4.350M	-5.230M	-$8.562M
YoY Change	-16.83%	193.82%	660.35%
FREE CASH FLOW
Cash From Operating Activities	-$4.350M	-$5.190M	-$8.562M
Capital Expenditures	$0.00	-$30.00K
Free Cash Flow	-$4.350M	-$5.160M
YoY Change	-15.7%	214.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80941524	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	siga	Accrued Researchand Development Vendor Costs Current AccruedResearchandDevelopmentVendorCostsCurrent	1446410	USD
CY2019Q2	siga	Accrued Researchand Development Vendor Costs Current AccruedResearchandDevelopmentVendorCostsCurrent	260276	USD
CY2019Q2	siga	Amount Received From Contractfor Developmentand Support Activities AmountReceivedFromContractforDevelopmentandSupportActivities	44500000	USD
CY2018Q4	siga	Computer Equipment Gross ComputerEquipmentGross	618248	USD
CY2019Q2	siga	Computer Equipment Gross ComputerEquipmentGross	581653	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2019Q1	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	23400000	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2018Q3	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	525000000	USD
	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	72700000	USD
	siga	Conversionof Warrantsto Common Stock ConversionofWarrantstoCommonStock	0	USD
	siga	Conversionof Warrantsto Common Stock ConversionofWarrantstoCommonStock	1172801	USD
CY2018Q2	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	360285	USD
	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	-2942829	USD
CY2019Q2	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	656523	USD
	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	3792788	USD
CY2018Q3	siga	Government Contract Base Valueof Award For Deliveryof Courses GovernmentContractBaseValueofAwardForDeliveryofCourses	11100000	USD
	siga	Government Contract Number Of Courses Purchased Under Modified Contract GovernmentContractNumberOfCoursesPurchasedUnderModifiedContract	1700000	contract
CY2011Q2	siga	Government Contract Numberof Additional Courses Purchased Under Modified Contract GovernmentContractNumberofAdditionalCoursesPurchasedUnderModifiedContract	300000	course
	siga	Government Contract Numberof Paymentstobe Paid Upon Deliveryof Bulk Drug Substance GovernmentContractNumberofPaymentstobePaidUponDeliveryofBulkDrugSubstance	3200000	USD
CY2018Q3	siga	Government Contract Paymentsfor Supportive Procurement Activities GovernmentContractPaymentsforSupportiveProcurementActivities	600000	USD
CY2011Q2	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	508700000	USD
CY2018Q3	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	600100000	USD
	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	32000000	USD
CY2018Q3	siga	Governmentcontractbasevalueawardfordeliveryandsupportactivities Governmentcontractbasevalueawardfordeliveryandsupportactivities	51700000	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	2942829	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	-3792788	USD
CY2018Q3	siga	Number Of Courses To Be Delivered1 NumberOfCoursesToBeDelivered1	1488000	course
CY2018Q3	siga	Numberof Courses Delivered Options Final Drug Product NumberofCoursesDeliveredOptionsFinalDrugProduct	35700	course
CY2019Q2	siga	Numberof Courses Dividedinto Procurement Related Options NumberofCoursesDividedintoProcurementRelatedOptions	363070	course
	siga	Numberof Courses Options Final Drug Product NumberofCoursesOptionsFinalDrugProduct	20000	course
CY2018Q3	siga	Numberof Courses Storedas Vendor Managed Inventory NumberofCoursesStoredasVendorManagedInventory	212000	course
CY2019Q1	siga	Numberof Coursesthat Paymentwas Receivedfor NumberofCoursesthatPaymentwasReceivedfor	23000	course
CY2018Q4	us-gaap	Assets Assets	203443741	USD
CY2019Q2	us-gaap	Assets Assets	203092260	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	121289845	USD
	siga	Stock Issued During Period Value Restricted Stock Unitsand Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueRestrictedStockUnitsandStockSettledAppreciationRightsExercised	0	USD
CY2019Q2	siga	Stock Issued During Period Value Restricted Stock Unitsand Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueRestrictedStockUnitsandStockSettledAppreciationRightsExercised	0	USD
	siga	Stock Issued During Period Value Restricted Stock Unitsand Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueRestrictedStockUnitsandStockSettledAppreciationRightsExercised	0	USD
CY2018Q3	siga	Numberof Primary Manufacturing Steps NumberofPrimaryManufacturingSteps	2	step
CY2019Q2	siga	Numberof Renewal Options NumberofRenewalOptions	2	option
CY2018Q3	siga	Numberofcoursesbasefinaldrugproduct Numberofcoursesbasefinaldrugproduct	8000000	USD
CY2018Q2	siga	Patent Preparation Fees PatentPreparationFees	178332	USD
	siga	Patent Preparation Fees PatentPreparationFees	396805	USD
CY2019Q2	siga	Patent Preparation Fees PatentPreparationFees	182310	USD
	siga	Patent Preparation Fees PatentPreparationFees	370226	USD
CY2019Q2	siga	Paymentfor Procurementof Raw Materials PaymentforProcurementofRawMaterials	11200000	USD
CY2019Q2	siga	Proceeds From Manufacture And Physical Delivery Of Courses Government Contracts ProceedsFromManufactureAndPhysicalDeliveryOfCoursesGovernmentContracts	459800000	USD
CY2019Q1	siga	Proceedsfor Deliveryof Courses ProceedsforDeliveryofCourses	7100000	USD
CY2019Q2	siga	Proceedsfor Deliveryof Courses ProceedsforDeliveryofCourses	34000000	USD
CY2018Q4	siga	Proceedsfrom Saleof Priority Review Voucher ProceedsfromSaleofPriorityReviewVoucher	78300000	USD
CY2019Q2	siga	Researchand Development Future Aggregate Amount ResearchandDevelopmentFutureAggregateAmount	4400000	USD
CY2018Q4	siga	Rightof Use Asset Gross RightofUseAssetGross	0	USD
CY2019Q2	siga	Rightof Use Asset Gross RightofUseAssetGross	2944932	USD
	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	2230153	USD
	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	2230153	USD
CY2018Q2	siga	Stock Issued During Period Value Restricted Stock Unitsand Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueRestrictedStockUnitsandStockSettledAppreciationRightsExercised	0	USD
	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1172801	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1688488	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1070926	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1959133	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4128216	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2600839	USD
CY2019Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1414720	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9648917	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10052283	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	242043	USD
CY2019Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	535944	USD
CY2018Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	294794	USD
CY2019Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	354206	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3244861	USD
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3464607	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	218697872	USD
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	220770338	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	362361	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	689721	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	547390	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	956284	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	121534950	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19857833	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10581112	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100652809	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100263915	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37101586	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23311779	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180396910	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175992939	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13789807	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4403971	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81046524	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81046524	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80763350	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80763350	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	8076	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	8105	USD
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	3300000	USD
	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	1000000	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	915367	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-223313	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9777	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-655139	USD
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4159946	USD
CY2019Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5364080	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	11733385	USD
CY2019Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	12388524	USD
CY2018Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4139	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33929	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	127566	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	265289	USD
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0004
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2019Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2615
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2859
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3792788	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	12380939	USD
CY2019Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7415350	USD
CY2018Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	377859	USD
CY2019Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	377859	USD
CY2018Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2019Q2	us-gaap	Goodwill Goodwill	898334	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7048415	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18633023	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4282181	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2146251	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2849	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	497	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1119689	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-613536	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-854097	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1848074	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	219547	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2169083	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-54776	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-553755	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1204135	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-517724	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-128917	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-135394	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-456818	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-705066	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-813682	USD
CY2018Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2069066	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1128137	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1179477	shares
CY2018Q2	us-gaap	Interest Expense InterestExpense	3843161	USD
	us-gaap	Interest Expense InterestExpense	7591979	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	3971031	USD
	us-gaap	Interest Expense InterestExpense	7899449	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	35567	USD
CY2019Q2	us-gaap	Interest Payable Current InterestPayableCurrent	965133	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	957765	USD
CY2019Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	68221	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	2908210	USD
CY2019Q2	us-gaap	Inventory Net InventoryNet	2390487	USD
CY2018Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	1950445	USD
CY2019Q2	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	2322266	USD
CY2018Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2019Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3641767	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1387139	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	402078	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	368467	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	600362	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	591108	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	292613	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	551116	USD
CY2018Q4	us-gaap	Liabilities Liabilities	100529054	USD
CY2019Q2	us-gaap	Liabilities Liabilities	99637793	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	203443741	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	203092260	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11337405	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11123209	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	75547597	USD
CY2019Q2	us-gaap	Long Term Debt LongTermDebt	77777748	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12328	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-56590	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27863	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8948	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13749616	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4338433	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-7051264	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18633520	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-3162492	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1532715	USD
CY2018Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-7411549	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-18633520	USD
CY2019Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3819015	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-5325503	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	144152	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	146387	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	737577	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1473706	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	6370907	USD
	us-gaap	Operating Expenses OperatingExpenses	12653752	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	5612861	USD
	us-gaap	Operating Expenses OperatingExpenses	13879991	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3709691	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8244602	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1705250	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	486704	USD
CY2018Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	USD
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	0	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	0	USD
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3090651	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	405244	USD
CY2018Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	USD
CY2019Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	0	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	0	USD
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M13D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3019928	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	541376	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	352000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	320774	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	304000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	304000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1197778	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	869318	USD
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	752680	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1058880	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	929963	USD
CY2018Q4	us-gaap	Other Liabilities OtherLiabilities	1263113	USD
CY2019Q2	us-gaap	Other Liabilities OtherLiabilities	3321486	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	27863	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	8948	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	175749	USD
CY2018Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12328	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12328	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	56590	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4317615	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3503932	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1172801	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3416135	USD
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6324472	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171274	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2859865	USD
	us-gaap	Related Party Costs RelatedPartyCosts	50000	USD
CY2018Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	200000	USD
CY2019Q2	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	50000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	100000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3312181	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6320007	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2038323	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6035604	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11452078	USD
CY2019Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11248400	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	68292023	USD
CY2019Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	64480624	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10701305	USD
CY2018Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	11028824	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11452078	USD
CY2019Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	11248400	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6542448	USD
CY2018Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1701843	USD
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	68292023	USD
CY2019Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	64480624	USD
	us-gaap	Restructuring Charges RestructuringCharges	19208	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	509937	USD
CY2019Q2	us-gaap	Restructuring Reserve RestructuringReserve	353396	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115791261	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-117323976	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2661216	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4409150	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3907611	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14366695	USD
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	59200000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2880394	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5936940	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3392228	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6558794	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	689721	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	956284	USD
	us-gaap	Stock Issued1 StockIssued1	105900	USD
	us-gaap	Stock Issued1 StockIssued1	118500	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-323138291	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-334616500	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	-341317731	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	102914687	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	106069569	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	103454467	USD
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	12380939	USD
CY2019Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7415350	USD
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81163386	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79066768	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82114661	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82129601	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79094320	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79066768	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80986524	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80950124	shares

Files In Submission

Name	View Source	Status
0001010086-19-000014-index-headers.html	Edgar Link	pending
0001010086-19-000014-index.html	Edgar Link	pending
0001010086-19-000014.txt	Edgar Link	pending
0001010086-19-000014-xbrl.zip	Edgar Link	pending
exhibit102-mod19redacted.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20190630.xml	Edgar Link	completed
siga-20190630.xsd	Edgar Link	pending
siga-20190630x10q.htm	Edgar Link	pending
siga-20190630_cal.xml	Edgar Link	unprocessable
siga-20190630_def.xml	Edgar Link	unprocessable
siga-20190630_lab.xml	Edgar Link	unprocessable
siga-20190630_pre.xml	Edgar Link	unprocessable
siga-exhibit3112019q2.htm	Edgar Link	pending
siga-exhibit3122019q2.htm	Edgar Link	pending
siga-exhibit3212019q2.htm	Edgar Link	pending
siga-exhibit3222019q2.htm	Edgar Link	pending
sigaexhibit104loanagreementa.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2019 Q2 Form 10-Q Financial Statement

#000101008619000014 Filed on August 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2019 Q2 Form 10-Q Financial Statement

#000101008619000014 Filed on August 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga